152 related articles for article (PubMed ID: 16136551)
21. Learning and memory after neonatal exposure to 3,4-methylenedioxymethamphetamine (ecstasy) in rats: interaction with exposure in adulthood.
Cohen MA; Skelton MR; Schaefer TL; Gudelsky GA; Vorhees CV; Williams MT
Synapse; 2005 Sep; 57(3):148-59. PubMed ID: 15945064
[TBL] [Abstract][Full Text] [Related]
22. Sex differences in the neurochemical and functional effects of MDMA in Sprague-Dawley rats.
Walker QD; Williams CN; Jotwani RP; Waller ST; Francis R; Kuhn CM
Psychopharmacology (Berl); 2007 Jan; 189(4):435-45. PubMed ID: 17019566
[TBL] [Abstract][Full Text] [Related]
23. Memory function and serotonin transporter promoter gene polymorphism in ecstasy (MDMA) users.
Reneman L; Schilt T; de Win MM; Booij J; Schmand B; van den Brink W; Bakker O
J Psychopharmacol; 2006 May; 20(3):389-99. PubMed ID: 16574713
[TBL] [Abstract][Full Text] [Related]
24. Acute effects of dexfenfluramine (d-FEN) and methylenedioxymethamphetamine (MDMA) before and after short-course, high-dose treatment.
Frederick DL; Ali SF; Gillam MP; Gossett J; Slikker W; Paule MG
Ann N Y Acad Sci; 1998 May; 844():183-90. PubMed ID: 9668676
[TBL] [Abstract][Full Text] [Related]
25. The effects of MDMA pretreatment on the behavioural effects of other drugs of abuse in the rat elevated plus-maze test.
Sumnall HR; O'Shea E; Marsden CA; Cole JC
Pharmacol Biochem Behav; 2004 Apr; 77(4):805-14. PubMed ID: 15099927
[TBL] [Abstract][Full Text] [Related]
26. Effects of fenfluramine, m-CPP and triazolam on repeated-acquisition in squirrel monkeys before and after neurotoxic MDMA administration.
Winsauer PJ; McCann UD; Yuan J; Delatte MS; Stevenson MW; Ricaurte GA; Moerschbaecher JM
Psychopharmacology (Berl); 2002 Feb; 159(4):388-96. PubMed ID: 11823891
[TBL] [Abstract][Full Text] [Related]
27. Acute and long-term consequences of single MDMA administration in relation to individual anxiety levels in the rat.
Ho YJ; Pawlak CR; Guo L; Schwarting RK
Behav Brain Res; 2004 Mar; 149(2):135-44. PubMed ID: 15129777
[TBL] [Abstract][Full Text] [Related]
28. Analysis of behavioral asymmetries in the elevated plus-maze and in the T-maze.
Schwarting RK; Borta A
J Neurosci Methods; 2005 Feb; 141(2):251-60. PubMed ID: 15661307
[TBL] [Abstract][Full Text] [Related]
29. Effect of ambient temperature and a prior neurotoxic dose of 3,4-methylenedioxymethamphetamine (MDMA) on the hyperthermic response of rats to a single or repeated ('binge' ingestion) low dose of MDMA.
Green AR; Sanchez V; O'Shea E; Saadat KS; Elliott JM; Colado MI
Psychopharmacology (Berl); 2004 May; 173(3-4):264-9. PubMed ID: 14726996
[TBL] [Abstract][Full Text] [Related]
30. Effects of 3,4-methylenedioxymethamphetamine and related amphetamines on autonomic and behavioral thermoregulation.
Jaehne EJ; Salem A; Irvine RJ
Pharmacol Biochem Behav; 2005 Jul; 81(3):485-96. PubMed ID: 15904952
[TBL] [Abstract][Full Text] [Related]
31. Effect of a serotonin depleting regimen of 3,4-methylenedioxymethamphetamine (MDMA) on the subsequent stimulation of acetylcholine release in the rat prefrontal cortex.
Nair SG; Gudelsky GA
Brain Res Bull; 2006 Apr; 69(4):382-7. PubMed ID: 16624669
[TBL] [Abstract][Full Text] [Related]
32. Serotonin transporter expression is not sufficient to confer cytotoxicity to 3,4-methylenedioxymethamphetamine (MDMA) in vitro.
Hayat S; Williams RJ; Rattray M
J Psychopharmacol; 2006 Mar; 20(2):257-63. PubMed ID: 16510483
[TBL] [Abstract][Full Text] [Related]
33. MDMA in adolescent male rats: decreased serotonin in the amygdala and behavioral effects in the elevated plus-maze test.
Faria R; Magalhães A; Monteiro PR; Gomes-Da-Silva J; Amélia Tavares M; Summavielle T
Ann N Y Acad Sci; 2006 Aug; 1074():643-9. PubMed ID: 17105959
[TBL] [Abstract][Full Text] [Related]
34. Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density.
McGregor IS; Clemens KJ; Van der Plasse G; Li KM; Hunt GE; Chen F; Lawrence AJ
Neuropsychopharmacology; 2003 Aug; 28(8):1472-84. PubMed ID: 12700695
[TBL] [Abstract][Full Text] [Related]
35. Damage of serotonergic axons and immunolocalization of Hsp27, Hsp72, and Hsp90 molecular chaperones after a single dose of MDMA administration in Dark Agouti rat: temporal, spatial, and cellular patterns.
Adori C; Andó RD; Kovács GG; Bagdy G
J Comp Neurol; 2006 Jul; 497(2):251-69. PubMed ID: 16705678
[TBL] [Abstract][Full Text] [Related]
36. MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat.
Clemens KJ; Van Nieuwenhuyzen PS; Li KM; Cornish JL; Hunt GE; McGregor IS
Psychopharmacology (Berl); 2004 May; 173(3-4):318-25. PubMed ID: 15029472
[TBL] [Abstract][Full Text] [Related]
37. The relationship between hyperthermia and glycogenolysis in 3,4-methylenedioxymethamphetamine-induced serotonin depletion in rats.
Darvesh AS; Gudelsky GA
Neurotoxicol Teratol; 2004; 26(4):571-7. PubMed ID: 15203179
[TBL] [Abstract][Full Text] [Related]
38. 3,4-Methylenedioxymethamphetamine administration on postnatal day 11 in rats increases pituitary-adrenal output and reduces striatal and hippocampal serotonin without altering SERT activity.
Williams MT; Schaefer TL; Ehrman LA; Able JA; Gudelsky GA; Sah R; Vorhees CV
Brain Res; 2005 Mar; 1039(1-2):97-107. PubMed ID: 15781051
[TBL] [Abstract][Full Text] [Related]
39. Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats.
Ball KT; Budreau D; Rebec GV
Eur J Neurosci; 2006 Jul; 24(1):217-28. PubMed ID: 16882018
[TBL] [Abstract][Full Text] [Related]
40. Effects of MDMA administration on scopolamine-induced disruptions of learning and performance in rats.
Winsauer PJ; Quinton MS; Porter JR; Corll CB; Moerschbaecher JM; Delatte MS; Leonard ST; Stroble SB
Pharmacol Biochem Behav; 2004 Nov; 79(3):459-72. PubMed ID: 15582017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
